{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:01:56Z","timestamp":1789066916299,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40257-016-0219-z","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T01:34:28Z","timestamp":1473384868000},"page":"643-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Drug-Induced Tactile Hallucinations Beyond Recreational Drugs"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1367-742X","authenticated-orcid":false,"given":"Mio","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"219_CR1","first-page":"58","volume":"96","author":"NC Vulink","year":"2016","unstructured":"Vulink NC. Delusional infestation: state of the art. Acta Derm Venereol. 2016;96:58\u201363.","journal-title":"Acta Derm Venereol."},{"key":"219_CR2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/CMR.00018-09","volume":"22","author":"RW Freudenmann","year":"2009","unstructured":"Freudenmann RW, Lepping P. Delusional infestation. Clin Microbiol Rev. 2009;22:690\u2013732.","journal-title":"Clin Microbiol Rev."},{"key":"219_CR3","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.","edition":"5"},{"key":"219_CR4","first-page":"199","volume":"7","author":"J Koo","year":"1995","unstructured":"Koo J. Psychodermatology: a practical manual for clinicians. Curr Probl Dermatol. 1995;7:199\u2013234.","journal-title":"Curr Probl Dermatol."},{"issue":"1","key":"219_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0019-5154.105309","volume":"58","author":"JW Wong","year":"2013","unstructured":"Wong JW, Koo J. Delusions of parasitosis. Indian J Dermatol. 2013;58(1):49\u201352.","journal-title":"Indian J Dermatol."},{"issue":"3","key":"219_CR6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/clinids\/9.3.433","volume":"9","author":"RF Wykoff","year":"1987","unstructured":"Wykoff RF. Delusions of parasitosis: a review. Rev Infect Dis. 1987;9(3):433\u20137.","journal-title":"Rev Infect Dis."},{"key":"219_CR7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.51.3.811","volume":"51","author":"CG Goetz","year":"1998","unstructured":"Goetz CG, Vogel C, Tanner CM, Stebbins GT. Early dopaminergic drug-induced hallucinations in Parkinsonian patients. Neurology. 1998;51:811\u20134.","journal-title":"Neurology."},{"key":"219_CR8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1176\/ajp.135.6.669","volume":"135","author":"C Moskovitz","year":"1978","unstructured":"Moskovitz C, Moses H, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psych. 1978;135:669\u201375.","journal-title":"Am J Psych."},{"key":"219_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jns.2014.10.014","volume":"347","author":"H Kataoka","year":"2014","unstructured":"Kataoka H, Sawa N, Sugie K, Ueno S. Dopamine agonists trigger tactile hallucinations in patients with Pakinson\u2019s Disease? J Neurol Sci. 2014;347:361\u20133.","journal-title":"J Neurol Sci."},{"issue":"7","key":"219_CR10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-2230.2010.03810.x","volume":"35","author":"S Flann","year":"2010","unstructured":"Flann S, Shotbolt J, Kessel B, et al. Three cases of delusional parasitosis caused by dopamine agonists. Clin Exp Dermatol. 2010;35(7):740\u20132.","journal-title":"Clin Exp Dermatol."},{"key":"219_CR11","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaad.2005.06.040","volume":"53","author":"B Swick","year":"2005","unstructured":"Swick B, Walling H. Drug-induced delusions of parasitosis during treatment of Parkinson\u2019s disease. J Am Acad Dermatol. 2005;53:1086\u20137.","journal-title":"J Am Acad Dermatol."},{"key":"219_CR12","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00415-002-0908-9","volume":"249","author":"G F\u00e9nelon","year":"2002","unstructured":"F\u00e9nelon G, Thobois S, Bonnet AM, Broussolle E, Tison F. Tactile hallucinations in Parkinson\u2019s disease. J Neurol. 2002;249:1699\u2013703.","journal-title":"J Neurol."},{"key":"219_CR13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp.63.1.120","volume":"63","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"1997","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Ort\u00ed-Pareja M, Gasalla T, Tall\u00f3n-Barranco A, Cabrera-Valdivia F, Fern\u00e1ndez-Lliria A. Cenesthetic hallucinations in a patient with Parkinson\u2019s disease. J Neurol Neurosur Psychiatry. 1997;63:120.","journal-title":"J Neurol Neurosur Psychiatry."},{"key":"219_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/02791072.1985.10472319","volume":"17","author":"J Wilcox","year":"1985","unstructured":"Wilcox J. Psychoactive properties of amantadine. J Psychoactive Drugs. 1985;17:51\u20133.","journal-title":"J Psychoactive Drugs."},{"key":"219_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jemermed.2004.02.017","volume":"27","author":"G Shepherd","year":"2004","unstructured":"Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med. 2004;27:147\u201351.","journal-title":"J Emerg Med."},{"key":"219_CR16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/cap.2013.0144","volume":"6","author":"GS Arora","year":"2014","unstructured":"Arora GS, Arora HK, Sidhu J, Najjar F. Tactile hallucinations with fluoxetine and methylphenidate. J Child Adolesc Psychopharmacol. 2014;6:360\u20131.","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"219_CR17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/JCP.0b013e31818ce752","volume":"28","author":"M Coskun","year":"2008","unstructured":"Coskun M, Zoroglu S. Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination. J Clin Psychopharmacol. 2008;28:723\u20135.","journal-title":"J Clin Psychopharmacol."},{"issue":"11","key":"219_CR18","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.4088\/JCP.v67n1122e","volume":"67","author":"A Charuvastra","year":"2006","unstructured":"Charuvastra A, Yaeger D. Tactile hallucinations associated with therapeutic doses of bupropion in 2 patients. J Clin Psychiatry. 2006;67(11):1820\u20131.","journal-title":"J Clin Psychiatry."},{"issue":"1","key":"219_CR19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00004714-198502000-00010","volume":"5","author":"B Liskin","year":"1985","unstructured":"Liskin B, Roose SP, Walsh BT, Jackson WK. Acute psychosis following phenelzine discontinuation. J Clin Psychopharm. 1985;5(1):46\u20137.","journal-title":"J Clin Psychopharm."},{"issue":"9","key":"219_CR20","first-page":"385","volume":"48","author":"CA Peabody","year":"1987","unstructured":"Peabody CA. Trazodone withdrawal and formication. J Clin Psychiatry. 1987;48(9):385.","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"219_CR21","first-page":"174","volume":"2","author":"AJ Hvizdos","year":"1983","unstructured":"Hvizdos AJ, Bennett JA, Wells BG, Rappaport KB, Mendel SA. Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine. Clin Pharm. 1983;2(2):174\u20138.","journal-title":"Clin Pharm."},{"key":"219_CR22","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1176\/ajp.135.11.1422","volume":"135","author":"MR Liebowitz","year":"1978","unstructured":"Liebowitz MR, Nuetzel EJ, Bowser AE, Klein DF. Phenelzine and delusions of parasitosis: a case report. Am J Psychiatry. 1978;135:1422\u201333.","journal-title":"Am J Psychiatry."},{"issue":"2","key":"219_CR23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.psym.2014.03.004","volume":"56","author":"CN Stanciu","year":"2015","unstructured":"Stanciu CN, Penders TM, Oxentine HN. Delusional infestation following misuse of prescription stimulants. Psychosomatics. 2015;56(2):210\u20132.","journal-title":"Psychosomatics."},{"key":"219_CR24","first-page":"624235","volume":"2012","author":"M Buscarino","year":"2012","unstructured":"Buscarino M, Saal J, Young JL. Delusional parasitosis in a female treated with mixed amphetamine salts: a case report and literature review. Case Rep Psychiatry. 2012;2012:624235.","journal-title":"Case Rep Psychiatry."},{"issue":"8","key":"219_CR25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/CHI.0b013e318067fd7c","volume":"46","author":"J Rashid","year":"2007","unstructured":"Rashid J, Mitelman S. Methylphenidate and somatic hallucinations. J Am Acad Child Psychiatry. 2007;46(8):945\u20136.","journal-title":"J Am Acad Child Psychiatry."},{"key":"219_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004703-198106000-00003","volume":"2","author":"JG Young","year":"1981","unstructured":"Young JG. Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action. J Dev Behav Pediatr. 1981;2:35\u20138.","journal-title":"J Dev Behav Pediatr."},{"issue":"5","key":"219_CR27","first-page":"464","volume":"1","author":"JR Horn","year":"1982","unstructured":"Horn JR, Rylander ML, Hicks HM. Propranolol-induced hallucinosis. Clin Pharm. 1982;1(5):464\u20138.","journal-title":"Clin Pharm."},{"issue":"7","key":"219_CR28","first-page":"366","volume":"300","author":"ML Kurland","year":"1979","unstructured":"Kurland ML. Organic brain syndrome with propranolol. N Engl J Med. 1979;300(7):366.","journal-title":"N Engl J Med."},{"key":"219_CR29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.2.5654.445","volume":"2","author":"RD Hinshelwood","year":"1969","unstructured":"Hinshelwood RD. Hallucinations and propranolol. Br Med J. 1969;2:445.","journal-title":"Br Med J."},{"issue":"Suppl","key":"219_CR30","first-page":"S348","volume":"33","author":"CA Moreira","year":"2016","unstructured":"Moreira CA, Soares AR, Maia G. Psychiatric antiepileptics side effects: a case report. Eur Psychiatry. 2016;33(Suppl):S348.","journal-title":"Eur Psychiatry."},{"issue":"11","key":"219_CR31","doi-asserted-by":"crossref","first-page":"e1330","DOI":"10.4088\/JCP.14cr09099","volume":"75","author":"HK Oh","year":"2014","unstructured":"Oh HK, Tebrewal P, Dhillon R. Lamotrigine-induced tactile hallucination. J Clin Psychiatry. 2014;75(11):e1330.","journal-title":"J Clin Psychiatry."},{"issue":"3","key":"219_CR32","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1176\/appi.neuropsych.13060130","volume":"26","author":"PV Shrestha","year":"2014","unstructured":"Shrestha PV, Syed A, Marwaha R. Lacosamide-induced tactile hallucinations in a patient with complex partial seizures. J Neuropsychiatry Clin Neurosci. 2014;26(3):E8\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci."},{"issue":"13","key":"219_CR33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2334-13-261","volume":"4","author":"JK Mukonzo","year":"2013","unstructured":"Mukonzo JK, Okwera A, Nakasujja N, et al. Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study. BMC Infect Dis. 2013;4(13):261.","journal-title":"BMC Infect Dis."},{"issue":"4","key":"219_CR34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/0003-4819-87-4-458","volume":"87","author":"LJ Brandt","year":"1977","unstructured":"Brandt LJ. Formication and azathioprine therapy. Ann Intern Med. 1977;87(4):458.","journal-title":"Ann Intern Med."},{"key":"219_CR35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2146\/ajhp130485","volume":"71","author":"LA Siemianowski","year":"2014","unstructured":"Siemianowski LA, Rosenheck JP, Whitman CB. Nalbuphine-induced psychosis treated with naloxone. Am J Health Syst Pharm. 2014;71:717\u201321.","journal-title":"Am J Health Syst Pharm."},{"issue":"10","key":"219_CR36","first-page":"11","volume":"9","author":"V Selvaraj","year":"2012","unstructured":"Selvaraj V, Skaf M, Sharma A, Farooq U, Frederick P. Eszopiclone-induced psychosis. Innov Clin Neurosci. 2012;9(10):11.","journal-title":"Innov Clin Neurosci."},{"issue":"5","key":"219_CR37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/09546634.2014.996513","volume":"26","author":"V Patel","year":"2015","unstructured":"Patel V, Koo JY. Delusions of parasitosis: suggested dialogue between dermatologist and patient. J Dermatolog Treat. 2015;26(5):456\u201360.","journal-title":"J Dermatolog Treat."},{"issue":"4","key":"219_CR38","first-page":"273","volume":"42","author":"DJ Elpern","year":"1988","unstructured":"Elpern DJ. Cocaine abuse and delusions of parasitosis. Cutis. 1988;42(4):273\u20134.","journal-title":"Cutis."},{"key":"219_CR39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archpsyc.1973.04200010020003","volume":"29","author":"DS Bell","year":"1973","unstructured":"Bell DS. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry. 1973;29:35\u201340.","journal-title":"Arch Gen Psychiatry."},{"issue":"5","key":"219_CR40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0006-3223(91)90322-D","volume":"30","author":"C Botschev","year":"1991","unstructured":"Botschev C, M\u00fcller N. Opiate receptor antagonists for delusions of parasitosis. Biol Psychiatry. 1991;30(5):530\u20131.","journal-title":"Biol Psychiatry."},{"key":"219_CR41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2003-39602","volume":"34","author":"J Vles","year":"2003","unstructured":"Vles J, Feron F, Hendriksen J, Jolles J, Van Kroonenburgh M, Weber W. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit. Neuropediatrics. 2003;34:77\u201380.","journal-title":"Neuropediatrics."},{"key":"219_CR42","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.mehy.2006.07.061","volume":"68","author":"M Huber","year":"2007","unstructured":"Huber M, Kirchler E, Karner M, et al. Delusional parasitosis and the dopamine transporter. A new insight of etiology? Med Hypotheses. 2007;68:1351\u20138.","journal-title":"Med Hypotheses."},{"key":"219_CR43","doi-asserted-by":"crossref","first-page":"938","DOI":"10.7326\/0003-4819-90-6-938","volume":"90","author":"ES Gershon","year":"1979","unstructured":"Gershon ES, Goldstein RE, Moss AJ, et al. Psychosis with ordinary doses of propranolol. Ann Intern Med. 1979;90:938\u20139.","journal-title":"Ann Intern Med."},{"issue":"6","key":"219_CR44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3109\/10826087909041908","volume":"14","author":"D Arensberg","year":"1979","unstructured":"Arensberg D, Wenger NK. Psychosis: a probable result of propranolol therapy. Int J Addict. 1979;14(6):785\u20137.","journal-title":"Int J Addict."},{"issue":"7\u20138","key":"219_CR45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/106002808401800709","volume":"18","author":"DJ McGahan","year":"1984","unstructured":"McGahan DJ, Wojslaw A, Prasad V, Blankenship S. Propranolol-induced psychosis. Ann Pharmacother. 1984;18(7\u20138):601\u20133.","journal-title":"Ann Pharmacother."},{"issue":"1","key":"219_CR46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.31887\/DCNS.2007.9.1\/jchuffman","volume":"9","author":"JC Huffman","year":"2007","unstructured":"Huffman JC, Stern TA. Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci. 2007;9(1):29\u201345.","journal-title":"Dialogues Clin Neurosci."},{"key":"219_CR47","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","volume":"35","author":"RA Glennon","year":"1984","unstructured":"Glennon RA, Titeler M, McKenney JD. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 1984;35:2505\u201311.","journal-title":"Life Sci."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0219-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-016-0219-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0219-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T23:46:20Z","timestamp":1657237580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-016-0219-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1007\/s40257-016-0219-z","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}